Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

NOVARTIS AG

(NOVN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
09/14/2020 09/15/2020 09/16/2020 09/17/2020 09/18/2020 Date
81.9(c) 83.06(c) 82.27(c) 82.3(c) 82.93(c) Last
4 772 060 6 300 748 9 241 833 6 353 354 12 398 131 Volume
+0.12% +1.42% -0.95% +0.04% +0.77% Change
More quotes
Financials (USD)
Sales 2020 49 760 M - -
Net income 2020 8 967 M - -
Net Debt 2020 18 028 M - -
P/E ratio 2020 22,6x
Yield 2020 3,47%
Sales 2021 52 836 M - -
Net income 2021 10 442 M - -
Net Debt 2021 12 968 M - -
P/E ratio 2021 19,4x
Yield 2021 3,59%
Capitalization 200 B 201 B -
EV / Sales 2020 4,39x
EV / Sales 2021 4,04x
Nbr of Employees 110 000
Free-Float 86,9%
More Financials
Company
Novartis is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by family of products as follows: - pharmaceutical products (79.5%): used to treat cardiovascular, respiratory, and dermatological diseases, gastrointestinal disorders, cancers, central nervous system disorders, hormone imbalances, etc.; - generic drugs (20.5%; Sandoz). Net sales... 
More about the company
Notations Surperformance© of Novartis AG
Trading Rating : Investor Rating :
More Ratings
All news about NOVARTIS AG
09/18Milan judge seizes 2.3 million euros from Novartis in fraud probe
RE
09/17Tech sell-off hits Wall St as jobless claims remain high
RE
09/17BioNTech buys German site from Novartis to boost vaccine output
RE
09/17BioNTech CEO expects vaccine can be fridge-stored for two weeks
RE
09/17BioNTech to Buy German Novartis Site to Expand Covid-19 Vaccine Production
DJ
09/16NOVARTIS : ties bond sale to malaria treatment access in sustainability push
RE
09/14NOVARTIS : aims to expand Beovu use after safety fears hurt launch
RE
09/14NOVARTIS : aims to expand Beovu use after safety fears hurt launch
RE
09/14European healthcare stocks hit by Trump drug order
RE
09/14Gilead Acquires Cancer-Drug Maker -- WSJ
DJ
09/13Gilead Reaches Deal to Buy Immunomedics for $21 Billion -- 5th Update
DJ
09/13Gilead Reaches Deal to Buy Immunomedics for $21 Billion--4th Update
DJ
09/10Genmab to Present at Morgan Stanley 18th Annual Global Healthcare Conference
AQ
09/10NOVARTIS AG : Raised to Buy by UBS
MD
09/09NOVARTIS : Roche, Genentech Get Joint EUR444 Million Fine From French Antitrust ..
DJ
More news
News in other languages on NOVARTIS AG
09:18aNovartis présente des données avec Piqray et Spartalizumab au congrès ESMO
09:05aNovartis präsentiert an ESMO Daten zu Piqray und Spartalizumab
09/18Bourse Zurich: les indices finissent la semaine dans le vert
09/18Aktien Schweiz Schluss: SMI schliesst dank starker Pharmawerte fester
09/18La justice milanaise saisit des fonds de Novartis pour fraude
More news
Analyst Recommendations on NOVARTIS AG
More recommendations
Chart NOVARTIS AG
Duration : Period :
Novartis AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NOVARTIS AG
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 107,12 $
Last Close Price 90,92 $
Spread / Highest target 42,5%
Spread / Average Target 17,8%
Spread / Lowest Target -10,4%
EPS Revisions
Managers
NameTitle
Vasant Narasimhan Chief Executive Officer
Hans Jörg Reinhardt Independent Non-Executive Chairman
Harry Werner Kirsch Chief Financial Officer
John Tsai Chief Medical Officer
Elizabeth Theophille Chief Technology & Digital Officer
Sector and Competitors
1st jan.Capitalization (M$)
NOVARTIS AG-9.76%200 978
JOHNSON & JOHNSON2.27%392 765
ROCHE HOLDING AG9.27%322 209
MERCK & CO., INC.-5.65%217 034
PFIZER, INC.-6.02%203 549
NOVO NORDISK A/S12.50%161 415